e-Article
Enhancing the value of PCSK9 monoclonal antibodies by identifying patients most likely to benefit. A consensus statement from the National Lipid Association
Document Type
Article
Author
Source
In Journal of Clinical Lipidology July-August 2019 13(4):525-537
Subject
Language
ISSN
1933-2874